GENE ONLINE|News &
Opinion
Blog

2020-09-27| SpecialTechnology

Combining the Power of miRNAs and Nanotechnology to Prevent Osteoarthritis Progression

by GeneOnline
Share To
miRNAs belong to the category of non-coding RNAs. They block the expression of a gene either by binding to its specific mRNA and degrading it or by preventing the translation of the specific mRNA. More than 1900 miRNAs have been discovered to date in humans, and many of them have been implicated in various human diseases. Changes in the expression of miRNA have been involved in diseases like cancer, obesity, cardiovascular diseases, and osteoarthritis (OA).
Several miRNAs have been identified that are differentially expressed in OA . One of the first miRNA that has been linked to OA pathology is miRNA-140.

GO Prime with only $1.49 now

LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top